580 related articles for article (PubMed ID: 35545027)
1. Mucosal immune responses to infection and vaccination in the respiratory tract.
Mettelman RC; Allen EK; Thomas PG
Immunity; 2022 May; 55(5):749-780. PubMed ID: 35545027
[TBL] [Abstract][Full Text] [Related]
2. Mucosal Immunity against SARS-CoV-2 in the Respiratory Tract.
Noh HE; Rha MS
Pathogens; 2024 Jan; 13(2):. PubMed ID: 38392851
[TBL] [Abstract][Full Text] [Related]
3. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
4. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
Nagai M; Moriyama M; Ichinohe T
mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
[TBL] [Abstract][Full Text] [Related]
5. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
6. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
Front Immunol; 2021; 12():801799. PubMed ID: 35222355
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.
Fröberg J; Diavatopoulos DA
Curr Opin Infect Dis; 2021 Jun; 34(3):181-186. PubMed ID: 33899752
[TBL] [Abstract][Full Text] [Related]
8. Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice.
Ashhurst AS; Johansen MD; Maxwell JWC; Stockdale S; Ashley CL; Aggarwal A; Siddiquee R; Miemczyk S; Nguyen DH; Mackay JP; Counoupas C; Byrne SN; Turville S; Steain M; Triccas JA; Hansbro PM; Payne RJ; Britton WJ
Nat Commun; 2022 Nov; 13(1):6972. PubMed ID: 36379950
[TBL] [Abstract][Full Text] [Related]
9. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2.
Jung HE; Ku KB; Kang BH; Park JH; Kim HC; Kim KD; Lee HK
Antiviral Res; 2023 Aug; 216():105656. PubMed ID: 37327877
[TBL] [Abstract][Full Text] [Related]
11. Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines.
Fraser R; Orta-Resendiz A; Mazein A; Dockrell DH
Trends Mol Med; 2023 Apr; 29(4):255-267. PubMed ID: 36764906
[TBL] [Abstract][Full Text] [Related]
12. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated Innate Immune and Inflammatory Responses in SARS-CoV-2 Infection and COVID-19 Severity.
Ghosh P; Nagaraja S; Basavaraju S; Kesavardhana S
Crit Rev Immunol; 2021; 41(3):43-56. PubMed ID: 35378010
[TBL] [Abstract][Full Text] [Related]
14. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
[TBL] [Abstract][Full Text] [Related]
15. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses.
Labarrere CA; Kassab GS
Front Immunol; 2021; 12():652252. PubMed ID: 34630377
[TBL] [Abstract][Full Text] [Related]
16. Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
Tomalka JA; Suthar MS; Deeks SG; Sekaly RP
Nat Immunol; 2022 Mar; 23(3):360-370. PubMed ID: 35210622
[TBL] [Abstract][Full Text] [Related]
17. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
[TBL] [Abstract][Full Text] [Related]
18. Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses.
Sinha D; Yaugel-Novoa M; Waeckel L; Paul S; Longet S
Antiviral Res; 2024 Mar; 223():105823. PubMed ID: 38331200
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell.
Girkin JLN; Maltby S; Bartlett NW
Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35508333
[TBL] [Abstract][Full Text] [Related]
20. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination.
Tang J; Zeng C; Cox TM; Li C; Son YM; Cheon IS; Wu Y; Behl S; Taylor JJ; Chakaraborty R; Johnson AJ; Shiavo DN; Utz JP; Reisenauer JS; Midthun DE; Mullon JJ; Edell ES; Alameh MG; Borish L; Teague WG; Kaplan MH; Weissman D; Kern R; Hu H; Vassallo R; Liu SL; Sun J
Sci Immunol; 2022 Oct; 7(76):eadd4853. PubMed ID: 35857583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
